Co-localization of GABA with other neuroactive substances in the basal ganglia

Progress in Brain Research

Volumn 160, Issue , 2007, Pages 273-284

  McGinty, Jacqueline F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

BDNF; dynorphin; enkephalin; striatum; substance P

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; DELTA OPIATE RECEPTOR; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DYNORPHIN; ENKEPHALIN; GLUTAMATE RECEPTOR; KAPPA OPIATE RECEPTOR; MESSENGER RNA; MU OPIATE RECEPTOR; MUSCARINIC RECEPTOR; NEUROKININ 1 RECEPTOR; NEUROMEDIN N; NEUROPEPTIDE; NEUROTENSIN; OPIATE PEPTIDE; SUBSTANCE P; TACHYKININ;

BASAL GANGLION; BEHAVIOR; BRAIN NERVE CELL; CELLULAR DISTRIBUTION; CORPUS STRIATUM; DIALYSATE; DOPAMINE RECEPTOR BLOCKING; GABAERGIC TRANSMISSION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; NERVE CELL NETWORK; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR BLOCKING; REGULATORY MECHANISM; REVIEW;

ANIMALS; BASAL GANGLIA; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURAL PATHWAYS; NEURONS; NEUROPEPTIDES; OPIOID PEPTIDES; RECEPTORS, NEUROPEPTIDE; SUBSTANCE P; SYNAPTIC TRANSMISSION;

EID: 34247855712     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(06)60016-2     Document Type: Review

References (88)

1. Adams D.H., Hanson G.R., and Keefe K.A. Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykiniin messenger RNA expression in unique regions of the striatum. Neuroscience 102 (2001) 843-851
2. Afifi A.K. The basal ganglia: functional anatomy and physiology, Part 1. J. Child Neurol. 9 (1994) 249-260
3. Anderson J.J., Kuo S., Chase T.N., and Engber T.M. Dopamine D1 receptor-stimulated release of acetylcholine in rat striatum is mediated by activavtion of striatal neurokinin1 receptors. J. Pharmacol. Exper. Therap. 269 (1994) 1144-1151
4. Anderson K.D., and Reiner A. Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionarily conserved feature of basal ganglia organization. J. Comp. Neurol. 295 (1990) 339-369
5. Angulo J.A., and McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19 (1994) 1-28
6. Aoki C., and Pickel V.M. Neuropeptide Y in cortex and striatum. Ultrastructural distribution and coexistence with classical neurotransmitters and neuropeptides. Ann. N. Y. Acad. Sci. 611 (1990) 186-205
7. Arenas E., Akerud P., Wong V., Boylan C., Persson H., Lindsay R.M., and Altar C.A. Effects of BDNF and NY-4/5 on striatonigral neuropeptides or nigral GABA neurons In Vivo. Eur. J. Neurosci. 8 (1996) 1707-1717
8. Bals-Kubik R., Shippenberg T.S., and Herz A. Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. Eur. J. Pharmacol. 175 (1990) 63-69
9. Binder E.B., Kinkead B., Owens M.J., and Nemeroff C.B. Neurotensin and dopamine interactions. Pharmacol. Rev. 53 (2001) 453-486
10. Boyes J., and Bolam J.P. The subcellular localization of GABA(B) receptor subunits in rat substantia nigra. Eur. J. Neurosci. 18 (2003) 3279-3293
11. Brebner K., Childress A.R., and Roberts D.C. A potential role for GABA(B) agonists in the treatment of psychostimulant addiction. Alcohol & Alcoholism 37 (2002) 478-484
12. Brebner K., Phelan R., and Roberts D.C. Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive ratio schedules. Psychopharmacology 143 (2000) 209-214
13. Calabresi P., De Murtas M., and Bernardi G. The neostriatum beyond the motor function: experimental and clinical evidence. Neuroscience 78 (1997) 39-60
14. Castel M.N., Morino P., Nylander I., Terenius L., and Hokfelt T. Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat. Eur. J. Pharmacol. 262 (1994) 1-10
15. Chu D.C., Albin R.L., Young A.B., and Penny J.B. Distribution and kinetics of GABAB binding sites in rat central nervous system: a quantitative autoradiographic study. Neuroscience 34 (1990) 341-357
16. Daunais J.B., and McGinty J.F. The effects of dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge. Mol. Brain Res. 35 (1994) 237-248
17. Daunais J.B., and McGinty J.F. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNA. Synapse 18 (1994) 35-45
18. Daunais J.B., Roberts D.C.S., and McGinty J.F. Short-term cocaine self administration increases preprodynorphin, but not preproenkephalin, c-fos or zif/268 mRNAs in rat forebrain. Brain Res. Bull. 37 (1995) 523-527
19. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concemtrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85 (1988) 4274-4278
20. Georges F., Stinus L., Bloch B., and Le Moine C. Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur. J. Neurosci. 11 (1999) 481-490
21. Gerfen C.R. The neostriatal mosaic. I. Compartmental organization of projections from the striatum to the substantia nigra in the rat. J. Comp. Neurol. 236 (1985) 454-456
22. Gerfen C.R., and Young III W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460 (1988) 161-167
23. Gonzalez-Nicolini M.V., Berglind W., Cole K.S., Keogh C.L., and McGinty J.F. Local mu and delta opioid receptors regulate amphetamine-induced behavior and neuropeptide mRNA in the striatum. Neuroscience 121 (2003) 387-398
24. Gonzalez-Nicolini V., and McGinty J.F. NK-1 receptor blockade decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Brain Res. 931 (2002) 41-49
25. Gray A.M., Rawls S.M., Shippenberg T.S., and McGinty J.F. The kappa opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. J. Neurochem. 73 (1999) 1066-1074
26. Graybiel A.M. Neuropeptides in the basal ganglia. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 64 (1986) 135-161
27. Guggenheim N.D., Klop H., Minami M., Satoh M., and Voorn P. Co-localization of μ receptor is greater with dynorphin than enkephalin in rat striatum. NeuroReport 7 (1996) 2119-2124
28. Hanson G.R., Letter A.A., Bush L., and Gibb J.W. Methamphetamine-induced changes in the striatal-nigral dynorphin system: role of D-1 and D-2 receptors. Eur. J. Pharmacol. 144 (1987) 245-246
29. Hanson G.R., Letter A.A., Bush L., and Gibb J.W. Characterization of methamphetamine effects on the striatal-nigral dynorphin system. Eur. J. Pharmacol. 155 (1988) 11-18
30. Hanson G.R., Smiley P., Johnson M., Letter A., Bush L., and Gibb J.W. Response by the neurotensin systems of the basal ganglia to cocaine treatment. Eur. J. Pharmacol. 160 (1989) 23-30
31. Heidbreder C., Goldberg S.R., and Shippenberg T.S. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 616 (1993) 335-338
32. Heidbreder C., Shoaib M., and Shippenberg T.S. Differential role of delta receptors in the development and expression of behavioral sensitization to cocaine. Eur. J. Pharmacol. 298 (1996) 207-216
33. Heijna M.H., Padt M., Hogenboom F., Portoghese P.S., Mulder A.H., and Schoffelmeer A.N.M. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur. J. Pharmacol. 18 (1990) 267-278
34. Holt D.J., Graybiel A.M., and Saper C.B. Neurochemical architecture of the human striatum. J. Comp. Neurol. 384 (1997) 1-25
35. Jones D.N.C., and Holtzman S.G. Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors. J. Pharmacol. Exper. Therap. 262 (1992) 638-645
36. Jones D.N.C., Bowen W.D., Portoghese P.S., and Holtzman S.G. Delta-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. Eur. J. Pharmacol. 249 (1993) 167-177
37. A receptors in dopamine agonist-induced behavior and gene expression. Brain Res. 836 (1999) 99-109
38. A receptor blockade does not alter D1/D2 interactions in the intact rat striatum. Neuroscience 102 (2001) 381-389
39. Kaneko S., Hikidi T., Watanabe D., Ichinose H., Nagatsu T., Kreitman R.J., Postan I., and Nakanishi S. Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function. Science 289 (2000) 633-637
40. Kaneko T., Shigemoto R., Nakanishi S., and Mizuno N. Substance P receptor-immunoreactive neurons in the rat striatum are segregated into somatostatinergic and cholinergic aspiny neurons. Brain Res. 631 (1993) 297-303
41. Kraft M., Ahluwahlia S., and Angulo J.A. Neurokini-1 receptor antagonists block acute cocaine-induced horizontal locomotion. Ann. N.Y. Acad. Sci. 977 (2001) 121-131
42. Kraft M., Noailles P., and Angulo J.A. Substance P modulates cocaine-induced dopamine overflow in the striatum of rat brain. Ann. N.Y. Acad. Sci. 977 (2001) 132-139
43. Kubota Y., and Kawaguchi Y. Spatial distributions of chemically identified intrinsic neurons in relation to patch and matrix compartments of rat neostriatum. J. Comp. Neurol. 332 (1993) 499-513
44. B receptors at glutamatergic synapses in the rat striatum. Neuroscience 136 (2005) 1083-1095
45. Le Moine C., Gaveriaux-Ruff C., Befort K., and Bloch B. Delta opioid receptor gene expression in the mouse forebrain: localization in cholinergic neurons of the striatum. Neuroscience 62 (1994) 635-640
46. Lubetski C., Chesselet M.-F., and Glowinski J. Modulation of dopamine release in striatal slices by delta opioid agonists. J. Pharmacol. Exper. Therap. 222 (1982) 435-440
47. Maisonneuve I.M., Archer S., and Glick S.D. U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in dialysate dopamine in the nucleus accumbens of rats. Neurosci. Lett. 181 (1994) 57-60
48. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7 (1987) 2445-2464
49. Meshul C.K., and McGinty J.F. Kappa opioid receptor immunoreactivity in nucleus accumbens shell and caudate-putamen is primarily associated with synaptic vesicles in axons. Neuroscience 96 (2000) 91-99
50. Merchant K.M., Hanson G.R., and Dorsa D.M. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects. J. Pharmacol. Exper. Therap. 269 (1994) 806-812
51. Meyer M.E., and Meyer M.E. Behavioral effects of the mu-opioid peptide agonists DAMGO, DALDA, and PL017 on locomotor activities. Pharmacol. Biochem. Behav. 46 (1993) 391-395
52. Mulder A.H., Wardeh G., Hogenboom F., and Frankhuyzen A.L. k- and d-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308 (1984) 278-280
53. B receptors. Synapse 14 (1993) 221-242
54. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20 (1995) 91-127
55. Pentney R.J.W., and Gratton A. Effects of local delta and mu opioid receptor activation of basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study. Neuroscience 45 (1995) 95-102
56. Petit F., Hamon M., Fournie-Zaluski M.C., and Roques B.P. Further evidence for a role of delta opiate receptor in the presynaptic regulation of newly synthesized dopamine release. Eur. J. Pharmacol. 126 (1986) 1-9
57. Rawls S.M., and McGinty J.F. L-trans-PDC-evoked striatal glutamate levels are attenuated by extracellular calcium reduction and glutamate receptor blockade. J. Neurochem. 68 (1997) 1553-1563
58. Rawls S.M., and McGinty J.F. Muscarinic receptors regulate extracellular glutamate levels in the rat striatum: an in vivo microdialysis study. J. Pharmacol. Exper. Therap. 286 (1998) 91-98
59. Rawls S.M., and McGinty J.F. Presynaptic kappa opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes. J. Neurochem. 73 (1999) 1058-1065
60. Rawls S.M., and McGinty J.F. Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the striatum: an in vivo microdialysis study. Brain Res. 861 (2000) 296-304
61. Sandor N.T., Lendvai B., and Vizi E.S. Effect of opiate antagonists on striatal acetylcholine and dopamine release. Brain Res. Bull. 29 (1992) 369-373
62. Saylor A.J., Meredith G.E., Vercillo M.S., Zahm D.S., and McGinty J.F. BDNF heterozygous mice demonstrate age-related changes in striatal and nigral gene expression. Exp. Neurol. 199 (2006) 362-372
63. Schad C.A., Justice J.B., and Holtzmann S.G. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J. Neurochem. 67 (1996) 2292-2299
64. Shippenberg T.S., and Heidbreder C. The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. Eur. J. Pharmacol. 280 (1995) 55-61
65. Shippenberg T.S., Bals-Kubik R., and Herz A. Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Res. 436 (1987) 234-239
66. Shippenberg T.S., LeFevour A., and Heidbreder C. Kappa opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. J. Pharmacol. Exp. Ther. 276 (1996) 545-554
67. Singh N.A., Midgley L.P., Bush L.G., Gibb J.W., and Hanson G.R. N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems. Brain Res. 555 (1991) 233-238
68. Smith A.J.W., and McGinty J.F. Acute amphetamine and methamphetamine alter opioid peptide mRNA expression in the rat striatum. Mol. Brain Res. 21 (1994) 359-362
69. Spanagel R., Herz A., and Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA 89 (1992) 2046-2050
70. Steiner H., and Gerfen C.R. Role of dynorphin and enkephalin in the regulation of straital output pathways and behavior. Exp. Brain Res. 123 (1998) 60-73
71. Steiner H., and Gerfen C.R. Enkephalin regulates acute D2 receptor antagonist-induced immediate-early gene expression in striatal neurons. Neurosci. 88 (1999) 795-810
72. Svingos A.L., Clarke C.L., and Pickel V.M. Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: implications for opiate and psychostimulant cross-sensitization. Synapse 34 (1999) 1-10
73. Svingos A.L., Chavkin C., Colago E.E., and Pickel V.M. Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles. Synapse 42 (2001) 185-192
74. Tzaferis J.A., and McGinty J.F. Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Mol. Brain Res. 93 (2001) 27-35
75. Ukai M., Kamiya T., Toyoshi T., and Kameyama T. Systemic administration of dynorphin A (1-13) markedly inhibits different behavioural responses induced by cocaine in the mouse. Neuropharmacol. 31 (1992) 843-849
76. Wang H., and Pickel V.M. Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal μ-opioid receptors. J. Neurosci. 21 (2001) 3242-3250
77. Wang J.Q., and McGinty J.F. D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse 22 (1996) 114-122
78. Wang J.Q., and McGinty J.F. Scopolamine augments c-fos and zif/268 mRNA expression induced by the full D1 dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience 72 (1996) 601-616
79. Wang J.Q., and McGinty J.F. Intrastriatal injection of the metabotropic glutamate receptor antagonist MCPG attenuates acute amphetamine-stimulated neuropeptide mRNA expression in rat striatum. Neurosci. Lett. 218 (1996) 13-16
80. Wang J.Q., and McGinty J.F. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats. Neuroscience 75 (1996) 43-56
81. Wang J.Q., and McGinty J.F. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: Regulation of D1/D2 interactions by muscarinic receptors. J. Pharmacol. Exper. Therap. 281 (1997) 972-982
82. Wang J.Q., and McGinty J.F. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats. Brain Res. 748 (1997) 62-70
83. Wang J.Q., and McGinty J.F. Glutamatergic and cholinergic regulation of immediate early gene and neuropeptide gene expression in the striatum. In: Merchant K. (Ed). Pharmacological Regulation of Gene Expression in the CNS (1998), CRC Press, Boca Raton 81-113
84. Werling L., Frattali A., Portoghese P., Takemori A., and Cox B. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J. Pharmacol. Exper. Therap. 246 (1988) 282-286
85. You Z.-B., Herrera-Marschitz M., Nylander I., Goiny M., O'Connor W.T., Ungerstedt U., and Terenius L. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists. Neuroscience 63 (1994) 427-434
86. Zahm D.S., Krause J.E., Welch M.A., and Grosu D.S. Distinct and interactive effects of d-amphetamine and haloperidol in levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat. J. Comp. Neurol. 400 (1998) 487-503
87. B receptor stimulation decreases amphetamine-induced neuropeptide mRNA expression in the striatum of rats. Brain Res. 1004 (2004) 18-28
88. Zhou W., Mailloux A., and McGinty J.F. Intracerebral baclofen administration decreases amphetamine-induced behavior and neuropeptide gene expression in the striatum. Neuropsychopharmacology 30 (2005) 880-890